Prioritized Health Outcomes for Adolescents and Young Adults with Acute Lymphoblastic Leukemia

• Two multidisciplinary guideline panels prioritized 34 outcomes for 32 research questions related to acute lymphoblastic leukemia in adolescents & young adults. • The prioritized outcomes can inform future primary studies, systematic reviews, and guidelines. The American Society of Hematology convened two multidisciplinary panels to develop guidelines for the management of acute lymphoblastic leukemia (ALL) among adolescents and young adults (AYAs). (1) Describe the process for selecting and prioritizing outcomes for 32 research questions relevant to the guideline development; (2) summarize the prioritized outcomes; and (3) describe the frequency of reporting of those outcomes in existing studies of AYAs with ALL. METHODS : The panels prioritized outcomes for each of 19 questions on frontline management, nine on management of relapsed/refractory disease, and four related to both topics. A 3-step process was used: (1) initial identification of outcomes; (2) online survey of all panel members to rate each outcome’s importance; and (3) iterative discussions among the panels to finalize the prioritized outcomes. We examined the frequency with which each prioritized outcome was reported for systematically reviewed research questions. The panels prioritized 34 unique outcomes across questions (median=7 outcomes per question). The most common outcomes were overall survival (27 questions; 84% of questions); relapse-, event-, disease-, or progression-free survival/relapse (27 questions; 84%), and quality-of-life (26 questions; 81%). Across 16 systematic reviews for which we found at least one study, each prioritized outcome was reported by a median of 25% of studies (interquartile range 20-48, range 0-79). The outcomes prioritized by multidisciplinary guideline panels can inform future primary studies, systematic reviews, and guidelines on ALL, other blood cancers, and AYAs. Future research should involve the development and adoption of a core outcome set for ALL.

Authors

Institutions

Publication Details

Journal
Blood Neoplasia
Published
2026-03-01
DOI
https://doi.org/10.1016/j.bneo.2026.100222
Primary Topic
Childhood Cancer Survivors' Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prioritized Health Outcomes for Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Kristen Marie O’Dwyer, Ghid Kanaan, John W. Melson, Teruhiko Terasawa et al.
Blood Neoplasia
Childhood Cancer Survivors' Quality of Life
article

Prioritized Health Outcomes for Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Kristen Marie O’Dwyer, Ghid Kanaan, John W. Melson, Teruhiko Terasawa, Matthew C. Cheung, Yuliia Sereda, Julie A. Wolfson, Sumit Gupta, Ian J. Saldanha, Ethan M. Balk, Htun Ja Mai, Wendy A. Stock
article en

Abstract

• Two multidisciplinary guideline panels prioritized 34 outcomes for 32 research questions related to acute lymphoblastic leukemia in adolescents & young adults. • The prioritized outcomes can inform future primary studies, systematic reviews, and guidelines. The American Society of Hematology convened two multidisciplinary panels to develop guidelines for the management of acute lymphoblastic leukemia (ALL) among adolescents and young adults (AYAs). (1) Describe the process for selecting and prioritizing outcomes for 32 research questions relevant to the guideline development; (2) summarize the prioritized outcomes; and (3) describe the frequency of reporting of those outcomes in existing studies of AYAs with ALL. METHODS : The panels prioritized outcomes for each of 19 questions on frontline management, nine on management of relapsed/refractory disease, and four related to both topics. A 3-step process was used: (1) initial identification of outcomes; (2) online survey of all panel members to rate each outcome’s importance; and (3) iterative discussions among the panels to finalize the prioritized outcomes. We examined the frequency with which each prioritized outcome was reported for systematically reviewed research questions. The panels prioritized 34 unique outcomes across questions (median=7 outcomes per question). The most common outcomes were overall survival (27 questions; 84% of questions); relapse-, event-, disease-, or progression-free survival/relapse (27 questions; 84%), and quality-of-life (26 questions; 81%). Across 16 systematic reviews for which we found at least one study, each prioritized outcome was reported by a median of 25% of studies (interquartile range 20-48, range 0-79). The outcomes prioritized by multidisciplinary guideline panels can inform future primary studies, systematic reviews, and guidelines on ALL, other blood cancers, and AYAs. Future research should involve the development and adoption of a core outcome set for ALL.

Blood Neoplasia
Sunnybrook Health Science Centre (CA), Johns Hopkins University (US), Fujita Health University (JP), Virginia Commonwealth University (US), Brown University (US), Health Sciences Centre (CA), University of Rochester Medical Center (US), University of Alabama at Birmingham (US), University of Chicago (US), SickKids Foundation (CA)
Openalex Percentile: Top 7%
Childhood Cancer Survivors' Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.